Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The Global Diabetic Retinopathy Market is anticipated to reach a valuation of USD 10329.7 million from USD 6647.3 million in 2021. It is...
[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031.Ocular drug delivery systems are...
/PRNewswire/ -- The "Global Diabetic Retinopathy Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners
Dublin, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The "Global Diabetic Retinopathy Market: Size, Share, Application Analysis, Regional Outlook, Growth Trends,...